R R

What Is a Microsphere Formulation?

A microsphere formulation contains small, generally spherical particles that carry a drug within or throughout a matrix. The particles are typically measured in micrometers and can be made from biodegradable polymers, lipids, proteins, or other materials. They can protect a drug, change where it travels, or control how quickly it is released. Many long-acting injectable products use polymer microspheres.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is a Microsphere Formulation?

A microsphere formulation contains small, generally spherical particles that carry a drug within or throughout a matrix. The particles are typically measured in micrometers and can be made from biodegradable polymers, lipids, proteins, or other materials. They can protect a drug, change where it travels, or control how quickly it is released. Many long-acting injectable products use polymer microspheres.

read more about microsphere formulation ...

Copy this HTML:

Copy HTML Copied!

What Are Microsphere Formulations Used For?

Microsphere formulations are used to extend drug release and reduce how frequently a medicine must be administered. They can also protect unstable ingredients, improve local delivery, or alter distribution in the body. Applications include long-acting hormone treatments, antipsychotic medicines, cancer therapies, vaccines, and other drug-delivery systems. The benefits depend on the particle material, drug properties, route, and target release profile.

How Do Microsphere Formulations Release Medicine?

Drug can be released as fluid enters the particle and the active ingredient diffuses outward. Release can also occur as a biodegradable polymer erodes or breaks down into smaller molecules. Some formulations combine diffusion, dissolution, swelling, and polymer degradation. Particle size, porosity, drug loading, polymer composition, and manufacturing conditions affect the release pattern.

How Are Microsphere Formulations Made?

Manufacturing methods include emulsion-solvent evaporation, spray drying, phase separation, and other microencapsulation techniques. The drug is mixed or encapsulated with the carrier material and formed into particles with a controlled size range. Residual solvents, moisture, particle shape, drug distribution, and encapsulation efficiency are tested. Injectable products also require sterility and reliable reconstitution or suspension before administration.

What Are the Benefits and Safety Considerations?

Microspheres can provide sustained exposure, fewer doses, and protection of sensitive drugs. Challenges include an initial burst of drug release, incomplete release, particle aggregation, variable degradation, and injection-site reactions. Once a long-acting dose is administered, it is generally difficult to remove or rapidly stop the drug release. Product quality depends heavily on particle characteristics, storage, preparation, and correct administration.

Frequently Asked Questions About Microsphere Formulations

Are microspheres the same as nanoparticles?

No. Microspheres are generally measured in micrometers, while nanoparticles are smaller and measured in nanometers. Their behavior, manufacturing, and uses can differ.

Are all microspheres biodegradable?

No. Many pharmaceutical microspheres use biodegradable polymers such as poly(lactic-co-glycolic acid), but other materials can persist longer or require different elimination pathways.

Why are microspheres used for long-acting injections?

The carrier can slow drug diffusion or degrade gradually after injection. This allows medicine to be released over an extended period.

What is burst release from a microsphere?

Burst release is a relatively rapid release of drug soon after administration, commonly from material near the particle surface. Formulation controls are used to keep it within an acceptable range.

References

FY2015 Regulatory Science Research Report: Long-Acting Injectable Formulations. U.S. Food and Drug Administration. https://www.fda.gov/industry/generic-drug-user-fee-amendments/fy2015-regulatory-science-research-report-long-acting-injectable-formulations. Date Accessed August 5, 2026.

PLGA-Based Biodegradable Microspheres in Drug Delivery: Recent Advances in Research and Application. Drug Delivery (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8248937/. Date Accessed August 5, 2026.

PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery. International Journal of Molecular Sciences (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8396256/. Date Accessed August 5, 2026.

LUPRON DEPOT (Leuprolide Acetate for Depot Suspension): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd. Date Accessed August 5, 2026.

RISPERDAL CONSTA (Risperidone Long-Acting Injection): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb34ee82-d2c2-43b8-ba21-2825c0954691. Date Accessed August 5, 2026.